Prebiotics, Probiotics, and Postbiotics for Acne Vulgaris: A Systematic Review
Open accessAbstract
INTRODUCTION: Microbiome-modulating therapies including prebiotics, probiotics, and postbiotics have been increasingly investigated as adjuncts or alternatives for managing acne vulgaris through effects on the gut-skin axis, inflammation, and barrier function. The objective of this systematic review is to characterize the safety and efficacy of oral and topical prebiotics, probiotics, and postbiotics in managing acne vulgaris. METHODS: We conducted a Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA)-guided systematic review of randomized controlled trials, cohort studies, and case-control studies evaluating oral and topical prebiotics, probiotics, and postbiotics for acne vulgaris from inception to August 2025 in PubMed, Embase, Web of Science, and Cochrane. Inclusion criteria comprised clinical studies reporting on safety and/or efficacy of topical and/or oral prebiotic, probiotic, and postbiotic therapy in patients with acne vulgaris. RESULTS: In total, 33 studies evaluating 2112 total patients were included, with treatment durations of 4-25 weeks; 5 prebiotic, 24 probiotic, and 7 postbiotic studies were included, with 2 studies comparing prebiotics and probiotics and 1 study comparing prebiotics and postbiotics against each other. Safety was favorable across all modalities with no serious adverse events reported. Pooled mean total lesion reductions were -37.2% for prebiotics, -45.2% for probiotics, and -49.5% for postbiotics, versus -37% for controls. CONCLUSIONS: Prebiotic, probiotic, and postbiotic therapies appear to be safe and associated with clinically meaningful lesion reductions in acne. They may increase tolerability and add additional efficacy to standard acne treatments including topical and oral antibiotics and retinoids. Probiotics currently have the strongest evidence base, while prebiotics and postbiotics are promising adjuncts. Larger, standardized randomized trials are needed to clarify comparative efficacy, optimal formulations, and durability.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Global Skin Disease Morbidity and Mortality: An Update From the Global Burden of Disease Study 2013
Karimkhani, C., Dellavalle, R. P., Coffeng, L. E., Flohr, C., Hay, R. J., Langan, S. M., Nsoesie, E. O., Ferrari, A. J., Erskine, H. E., Silverberg, J. I., et al. (2017) · JAMA Dermatology · doi:10.1001/jamadermatol.2016.5538 · Cited by 742 · see citing works
Guidelines of care for the management of acne vulgaris
Reynolds, R. V., Yeung, H., Cheng, C. E., Cook-Bolden, F., Desai, S. R., Druby, K. M., Freeman, E. E., Keri, J. E., Stein Gold, L. F., Tan, J. K. L., et al. (2024) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2023.12.017 · Cited by 518 · cited 1× · see citing works
“[7] The gut–skin axis and human microbiome have been increasingly investigated, generating interest in the potential of microbiome-modu-latory agents as treatments for various diseases, including acne vulgaris.”
Self-citationThe effect of probiotics on immune regulation, acne, and photoaging
Kober, M.-M., & Bowe, W. P. (2015) · International Journal of Women’s Dermatology · doi:10.1016/j.ijwd.2015.02.001 · Cited by 190 · see citing works
Kamenov, Z., & Gateva, A. (2020) · Molecules · doi:10.3390/molecules25235566 · Cited by 100 · cited 1× · see citing works
“Myoinositol regulates hormonal influences for acne mainly by decreasing testosterone levels [47].”
Flagged first, then by citations
- Authors
- Warp, P. V., Bilik, S. M., Ferrari, L. M., & Keri, J. E.
- Affiliations
- University of Miami (US)
- Corresponding author
- Keri, Jonette E.
- Venue
- Dermatology and Therapy
- Published
- 2026-02-17
- Volume
- 16
- Issue
- 3
- Pages
- 1531-1550
- ISSN
- 2190-9172 (ISSN-L)
- 2193-8210
- OpenAlex
- W7129243568
- Cited by
- 8
- References
- 4
- Citations by year
- 2026: 8
- FWCI
- 10.17
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Dermatology and Therapy (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Dermatology › Acne and Rosacea Treatments and Effects
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
- Keywords
- acne, prebiotics, probiotics, postbiotics, gut-skin axis, topical treatment, oral therapy, lesion reduction, treatment safety, adjunctive therapy, skin microbiome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review